Dehydroandrographolide Succinate

• CAT Number: R025464
• CAS Number: 786593-06-4
• Molecular Formula: C28H36O10
• Molecular Weight: 532.586
• Purity: ≥95%
• Storage: 3 years -20C powder
• IUPAC Name: 4-[[(1R,2R,4aR,5R,8aS)-2-(3-carboxypropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoic acid
• InChI: InChI=1S/C28H36O10/c1-17-4-7-20-27(2,19(17)6-5-18-13-15-36-26(18)35)14-12-21(38-25(34)11-9-23(31)32)28(20,3)16-37-24(33)10-8-22(29)30/h5-6,13,19-21H,1,4,7-12,14-16H2,2-3H3,(H,29,30)(H,31,32)/b6-5+/t19-,20+,21-,27+,28+/m1/s1
• InChIKey: YTHKMAIVPFVDNU-GPTWTFMPSA-N
• SMILES: CC12CCC(C(C1CCC(=C)C2C=CC3=CCOC3=O)(C)COC(=O)CCC(=O)O)OC(=O)CCC(=O)O

Dehydroandrographolide Succinate(CAT: R025464) is a synthetic derivative of andrographolide, a bioactive compound found in the Andrographis paniculata plant. Its mode of action involves being a succinate ester form of dehydroandrographolide. Pharmacologically, Dehydroandrographolide Succinate is not used as a therapeutic drug on its own. Instead, it is likely used in pharmaceutical research as a prodrug form of dehydroandrographolide to improve its solubility, stability, or bioavailability. Prodrug strategies are often employed to enhance the pharmacological properties of active compounds, and Dehydroandrographolide Succinate serves as an essential tool in drug development and optimization efforts.